Abbott Laboratories
LSE:0Q15
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
LSE:0Q15
|
US |
|
R
|
Ray Co Ltd
KOSDAQ:228670
|
KR |
|
S
|
SNP Schneider Neureither & Partner SE
XHAM:SHF
|
DE |
|
B
|
Bayerische Motoren Werke AG
XBER:BMW
|
DE |
|
S
|
Sierra Bancorp
NASDAQ:BSRR
|
US |
|
P
|
Premia SA
ATHEX:PREMIA
|
GR |
|
G
|
Guotai Junan International Holdings Ltd
XBER:GUE
|
HK |
|
B
|
British American Tobacco PLC
XBER:BMT
|
UK |
Dividends
Dividend Yield
Abbott Laboratories
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Abbott Laboratories
0Q15 have increased by 87%.
Payout Ratio
Abbott Laboratories
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0Q15 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0Q15 Price
Abbott Laboratories
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -35% |
| Market Capitalization | 151.8B USD |
| Shares Outstanding | 1 751 220 000 |
| Percentage of Shares Shorted |
N/A
|
